Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery – Brazilian Heart Study 2 (ADDENDA-BHS2)

Data from the study Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery – Brazilian Heart Study 2 (ADDENDA-BHS2, ClinicalTrials.gov Identifier: NCT 02919345), used in the sub-analysis that resulted in the article and thesis "Effect of dapagliflozin on diastolic function in high cardiovascular risk diabetics: ADDENDA-BHS2 randomized clinical trial." Evaluation data of 96 patients selected for the substudy that evaluated diastolic function and the association between improvement in vascular function and diastolic function, after 12 weeks of treatment with dapagliflozin compared to glibenclamide.